Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
Journal of Molecular Biology|November 4, 2000
X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificityN B Cronin, M O Badasso, I J Tickle, et al.JAMA Pediatrics|November 11, 2024
Prevalence of Adverse Childhood Experiences in Child Population Samples: A Systematic Review and Meta-AnalysisSheri Madigan, Raela Thiemann, Audrey-Ann Deneault, et al.Psychological Services|May 4, 2018
Development and validation of a measure of PTSD-related psychosocial functional impairment: The Inventory of Psychosocial FunctioningMichelle J Bovin, Shimrit K Black, Paola Rodriguez, et al.Bioorganic & Medicinal Chemistry Letters|August 18, 1999
4-hydroxy-5,6-dihydro-2H-pyran-2-ones.3. Bicyclic and hetero-aromatic ring systems as 3-position scaffolds to bind to S1' and S2' of the HIV-1 protease enzymeE L Ellsworth, J Domagala, J V Prasad, et al.Journal of Medicinal Chemistry|July 21, 1995
Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitorsM S Plummer, A Shahripour, J S Kaltenbronn, et al.Journal of Medicinal Chemistry|November 26, 1993
Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitorsE A Lunney, H W Hamilton, J C Hodges, et al.Journal of Medicinal Chemistry|March 17, 1995
Nonpeptidic potent HIV-1 protease inhibitors: (4-hydroxy-6-phenyl-2-oxo-2H- pyran-3-yl)thiomethanes that span P1-P2' subsites in a unique mode of active site bindingJ V Prasad, K S Para, P J Tummino, et al.Journal of Medicinal Chemistry|August 1, 1981
Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitorsR F Meyer, E D Nicolaides, F J Tinney, et al.Journal of Medicinal Chemistry|March 20, 1992
Renin inhibitors containing alpha-heteroatom amino acids as P2 residuesJ T Repine, J S Kaltenbronn, A M Doherty, et al.Journal of Medicinal Chemistry|June 1, 1986
Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agentsE D Nicolaides, F J Tinney, J S Kaltenbronn, et al.Pageof 8